Evidence map›Paper›PMID 38976101›Full record

ArticleEJNMMI research2024

Preclinical evaluation of [

Seweryn Krajewski, Lukasz Steczek, Karina Gotowicz, Urszula Karczmarczyk, Joanna Towpik, Ewa Witkowska-Patena, Krzysztof Łyczko, Maciej Mazur, Przemysław Kozanecki, Joanna Włostowska and 4 more

Abstract read
In one paragraph

Article in EJNMMI research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Biodistribution, Safety Profile, and Radiation Dosimetry of [Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2025
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Seweryn KrajewskiResearch & Development Centre, Synektik SA, Warsaw, Poland. skrajewski@synektik.com.pl.ORCID http://orcid.org/0009-0006-4048-9842
Lukasz SteczekResearch & Development Centre, Synektik SA, Warsaw, Poland.
Karina GotowiczResearch & Development Centre, Synektik SA, Warsaw, Poland.
Urszula KarczmarczykRadioisotope Centre POLATOM, National Centre for Nuclear Research, Otwock, Poland.
Joanna TowpikResearch & Development Centre, Synektik SA, Warsaw, Poland.
Ewa Witkowska-PatenaNuclear Medicine Department, Military Institute of Medicine - National Research Institute, Warsaw, Poland.
Krzysztof ŁyczkoInstitute of Nuclear Chemistry and Technology, Warsaw, Poland.
Maciej MazurDepartment of Chemistry, University of Warsaw, Warsaw, Poland.
Przemysław KozaneckiResearch & Development Centre, Synektik SA, Warsaw, Poland.
Joanna WłostowskaResearch & Development Centre, Synektik SA, Warsaw, Poland.
Juhani KnuutiTurku PET Centre, Turku University Hospital and University of Turku, Turku, Finland.
Mirosław DziukNuclear Medicine Department, Military Institute of Medicine - National Research Institute, Warsaw, Poland.
Piotr GarnuszekRadioisotope Centre POLATOM, National Centre for Nuclear Research, Otwock, Poland.
Cezary KozaneckiResearch & Development Centre, Synektik SA, Warsaw, Poland.

Funding

Narodowe Centrum Badań i Rozwoju POIR.01.01.01-00-0089/15
6 · The paper itself

Abstract

backgroundPositron emission tomography (PET) is now an established diagnostic method for myocardial perfusion imaging (MPI) in coronary artery disease, which is the main cause of death globally. The available tracers show several limitations, therefore, the

resultsThe dynamic microPET images showed rapid myocardial uptake for both tracers. However, the uptake was higher and also stable for [

conclusion[

Indexed as

CardiotracerDosimetryFluorine-18PET MPIPreclinical studies

Identifiers

PMID38976101
PMCPMC11231114

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.